Condition: Cardiac Rhythm Disorders · Urological Disorders · Neurological Disorders · Sponsor: Medtronic
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
This description comes directly from the study's public registry record.
Medtronic Product Surveillance Registry · rs.productsurveillanceregistry@medtronic.com
Always discuss trial participation with your own doctor first.
| Study site | Birmingham, Alabama, United States | Recruiting |
| Study site | Huntsville, Alabama, United States | Recruiting |
| Study site | Chandler, Arizona, United States | Recruiting |
| Study site | Phoenix, Arizona, United States | Recruiting |
| Study site | Little Rock, Arkansas, United States | Recruiting |
| Study site | Aliso Viejo, California, United States | Recruiting |
| Study site | Chula Vista, California, United States | Recruiting |
| Study site | Colton, California, United States | Recruiting |
| Study site | La Jolla, California, United States | Recruiting |
| Study site | Los Angeles, California, United States | Recruiting |
| Study site | Napa, California, United States | Recruiting |
| Study site | Redwood City, California, United States | Recruiting |
+ 388 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01524276